Displaying drugs 10401 - 10425 of 10872 in total
Avenciguat
Avenciguat is under investigation in clinical trial NCT05282121 (A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)).
Investigational
Matched Description: … Avenciguat is under investigation in clinical trial NCT05282121 (A Study to Test Whether BI 685509 Alone ... or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or ... Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going …
Prostaglandin G2
A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem]
Experimental
Matched Iupac: … (5Z)-7-[(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept- …
Matched Description: … A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. ... It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem] …
Matched Description: … A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. ... It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem] …
Gefarnate
Gefarnate has been investigated for the treatment and prevention of Stomach Ulcer, Duodenal Ulcer, and Cardio-cerebrovascular Disease.
Investigational
Matched Description: … Gefarnate has been investigated for the treatment and prevention of Stomach Ulcer, Duodenal Ulcer, and …
Brilacidin
Brilacidin is under investigation for the supportive care of Mucositis, Stomatitis, Mouth Diseases, and Head and Neck Neoplasms.
Investigational
Matched Description: … Brilacidin is under investigation for the supportive care of Mucositis, Stomatitis, Mouth Diseases, and …
Tinlorafenib
Tinlorafenib (PF-07284890) is a potent, selective, highly brain-penetrant, small-molecule inhibitor of BRAF V600 mutations.
Investigational
Matched Description: … Tinlorafenib (PF-07284890) is a potent, selective, highly brain-penetrant, small-molecule inhibitor of …
QL1706
QL1706 is an investigational bifunctional antibody that combines the activity of both PD-1 and CTLA-4 antibodies.
Investigational
Matched Description: … QL1706 is an investigational bifunctional antibody that combines the activity of both PD-1 and CTLA-4 …
Allopurinol riboside
Allopurinol riboside is a nucleoside analogue of allopurinol with a beta-D-ribofuranosyl moiety at the 1-position.
Investigational
Matched Description: … Allopurinol riboside is a nucleoside analogue of [allopurinol] with a beta-D-ribofuranosyl moiety at …
PMC-403
PMC-403 is a novel Tie2-activating antibody being investigated for the treatment of systemic capillary leak syndrome.
Investigational
Matched Description: … PMC-403 is a novel Tie2-activating antibody being investigated for the treatment of systemic capillary …
OptPA
Optimized tPA (OptPA; W253R/R275S-tPA) is an engineered variant of tPA designed to exhibit reduced neurotoxicity.
Investigational
Matched Description: … Optimized tPA (OptPA; W253R/R275S-tPA) is an engineered variant of tPA designed to exhibit reduced neurotoxicity …
Nendratareotide uzatansine
Nendratareotide uzatansine is a peptide-drug conjugate comprising a peptide analog of somatostatin conjugated to the cytotoxin mertansine.
Investigational
Matched Description: … Nendratareotide uzatansine is a peptide-drug conjugate comprising a peptide analog of somatostatin conjugated …
Avoplacel
Avoplacel (PLX-R18) is an allogeneic cell therapy under investigation for the treatment of acute radiation syndrome.
Investigational
Matched Description: … Avoplacel (PLX-R18) is an allogeneic cell therapy under investigation for the treatment of acute radiation …
Oleandomycin
Oleandomycin is a macrolide antibiotic, though it is less effective than erythromycin. It is synthesized from strains of Streptomyces antibioticus.
Vet approved
Matched Description: … It is synthesized from strains of _Streptomyces antibioticus_. …
Lenomorelin
Lenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.
Investigational
Matched Description: … Lenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism …
Varespladib
Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive Crisis, and Acute Coronary Syndrome.
Investigational
Matched Description: … Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive …
SRT-2104
SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular, and Diabetes Mellitus, Type 2.
Investigational
Matched Description: … SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular …
DTx-1252
DTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease type 1A (CMTD1A).
Investigational
Matched Description: … DTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease …
CLBS12
CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.
Investigational
Matched Description: … GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of …
BBT-877
BBT-877 is an autotaxin enzyme inhibitor being investigated for the treatment of fibrotic diseases, such as idiopathic pulmonary fibrosis.
Investigational
Matched Description: … BBT-877 is an autotaxin enzyme inhibitor being investigated for the treatment of fibrotic diseases, such …
Alovudine F-18
Alovudine F-18 is under investigation in clinical trial NCT02819024 (Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography).
Investigational
Matched Description: … Alovudine F-18 is under investigation in clinical trial NCT02819024 (Dexamethasone Effects in Patients …
AGuIX
AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates. It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma.
Investigational
Matched Description: … AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates ... It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma …
Nona-arginine
Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).
Investigational
Matched Description: … Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs …
Anfibatide
Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).
Investigational
Matched Description: … Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial …
Nicotinamide riboside
Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).
Investigational
Matched Description: … Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and …
SEphB4-HSA
SEphB4-HSA is under investigation in clinical trial NCT02495896 (Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors).
Investigational
Matched Description: … SEphB4-HSA is under investigation in clinical trial NCT02495896 (Recombinant EphB4-HSA Fusion Protein ... With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors). …
Y-27632
Y-27632 is an inhibitor of Rho-associated protein kinase. It inhibits calcium sensitization to affect smooth muscle relaxation.
Experimental
Matched Description: … Y-27632 is an inhibitor of Rho-associated protein kinase. …
Displaying drugs 10401 - 10425 of 10872 in total